Presenting at CPHI Japan

2023/02/20

Our Board director and CSO, Mitsuo Umetsu will be presenting the ideal business platform for international pharma professionals, CPHI Japan on April 19 - 21, 2023.

https://www.informa-japan.com/cphifcj/seminar/index.php?category=88#6A-08

RevolKa announces the closing of ￥250 million series A extension funding to accelerate Drug-Discovery programs

RevolKa Started joint research of a drug discovery program for rare diseases

RevolKa launched a drug discovery program for rare diseases

Related Articles